| Univariate | Multivariate | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
n | OR | 95% CI | P-value | OR | 95% CI | P-value | |||||
Age < 75 vs. ≥75 years | 312 | n.c. |  |  |  |  | – |  |  |  |  |
Sex Female (vs. Male) | 312 | 1.162 | 0.510 | , | 2.647 | 0.720 | – |  |  |  |  |
Anti-cancer drug | 312 |  |  |  |  |  | – |  |  |  |  |
 L-OHP | 178 | 1.000 |  | ref |  |  |  |  |  |  |  |
 CPT11 | 60 | 1.676 | 0.636 | , | 4.420 | 0.296 |  |  |  |  |  |
 CBDCA | 74 | 0.920 | 0.316 | , | 2.679 | 0.878 |  |  |  |  |  |
Oral 5-FU | 312 |  |  |  |  |  | – |  |  |  |  |
 Nothing | 157 | 1.000 |  | ref |  |  |  |  |  |  |  |
 S-1 | 30 | 1.859 | 0.556 | , | 6.210 | 0.314 |  |  |  |  |  |
 Capecitabine | 125 | 0.938 | 0.382 | , | 2.301 | 0.888 |  |  |  |  |  |
Additional oral steroid days 2 or 3 (vs. Nothing) | 312 | 1.203 | 0.531 | , | 2.726 | 0.658 | – |  |  |  |  |
NK1RA (vs. Nothing) | 312 | 1.175 | 0.474 | , | 2.913 | 0.728 | – |  |  |  |  |
Primary organ | 312 |  |  |  |  |  | – |  |  |  |  |
 colorectal cancer | 211 | 1.000 |  | ref |  |  |  |  |  |  |  |
 gastric cancer | 25 | n.c. |  |  |  |  |  |  |  |  |  |
 lung cancer | 23 | 1.516 | 0.412 | , | 5.572 | 0.531 |  |  |  |  |  |
 gynecological cancer | 53 | 0.606 | 0.173 | , | 2.131 | 0.435 |  |  |  |  |  |
Hb < 10 mg/dl | 312 | 1.010 | 0.443 | , | 2.301 | 0.981 | – |  |  |  |  |
Neut < 1500/μl | 312 | 0.528 | 0.068 | , | 4.096 | 0.541 | – |  |  |  |  |
PLT < 7.5 × 104/μl | 312 | 1.078 | 0.473 | , | 2.457 | 0.858 | – |  |  |  |  |
CRE ≥1.1 mg/dl | 312 | 6.643 | 1.848 | , | 23.881 | 0.004 | 12.601 | 2.437 | , | 65.157 | 0.003 |
AST > 2.5 ULN | 312 | 1.576 | 0.651 | , | 3.815 | 0.313 | – |  |  |  |  |
ALT > 2.5 ULN | 312 | 1.936 | 0.767 | , | 4.890 | 0.162 | – |  |  |  |  |
Fever elevation > 38 °C | 312 | 1.696 | 0.363 | , | 7.921 | 0.502 | – |  |  |  |  |
Constipation | 312 | 1.218 | 0.506 | , | 2.933 | 0.661 | – |  |  |  |  |
Diarrhea | 312 | 3.241 | 1.397 | , | 7.522 | 0.006 | 2.594 | 0.984 | , | 6.834 | 0.054 |
Oral mucositis | 312 | 2.189 | 0.940 | , | 5.099 | 0.069 | – |  |  |  |  |
Taste alteration | 312 | 1.895 | 0.833 | , | 4.314 | 0.128 | – |  |  |  |  |
Neuropathy | 312 | 2.916 | 1.064 | , | 7.986 | 0.037 | 1.088 | 0.346 | , | 3.423 | 0.885 |
Eruption | 312 | 3.630 | 1.470 | , | 8.965 | 0.005 | 2.012 | 0.716 | , | 5.657 | 0.185 |
General fatigue | 312 | 4.085 | 1.492 | , | 11.180 | 0.006 | 3.728 | 1.098 | , | 12.661 | 0.035 |
NRS ≥1 | 312 | 1.406 | 0.598 | , | 3.309 | 0.435 | – |  |  |  |  |
PS | 312 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 0 | 155 | 1.000 |  | ref |  |  | 1.000 |  | ref |  |  |
 1 | 146 | 3.435 | 1.215 | , | 9.708 | 0.020 | 2.568 | 0.820 | , | 8.043 | 0.105 |
 2 | 11 | 25.000 | 5.668 | , | 110.271 | 0.000 | 19.829 | 3.200 | , | 122.865 | 0.001 |